Our primary manufacturing facilities are located in the Fengxian Industrial Park in the greater Shanghai area. The facilities have been fully GMP operational since 2011. The highly experienced technical and plant operation teams, including project management and customer service teams, have the expertise and experience to ensure a seamless process development, technical transfer and scale-up to commercial manufacturing quantities as programs advance in their development to commercial launch.
- Scale-up capabilities in the kilo-lab and pilot plant
- Cryogenic, pressure (including hydrogenation and carbonylation), and high temperature capabilities
- Large scale manufacturing of high value intermediates, registration starting materials and APIs from the kilogram to ton scale under both non-GMP and GMP conditions supporting GLP toxicological studies through Phase I-III clinical studies and commercial launch.
The second phase build-out of the Fengxian facility is under way and includes construction of commercial manufacturing facilities. This will add considerable capacity to our existing manufacturing capabilities.